SCHEMBL7306927

SCHEMBL7306927

CCCc1nc(C(C)=O)c(C(=O)OCC)[nH]1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
HPGD P15428 2/20 0.44
KDM4E B2RXH2 2/20 0.44
HTT P42858 2/20 0.44
RECQL P46063 1/20 0.44
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MAPK1 P28482 2/20 0.42
TSHR P16473 1/20 0.38
XBP1 P17861 1/20 0.38
POLB P06746 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSP90AA1 P07900 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7303130 0.91 ALDH1A1 (0.42) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL1275935 0.91 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EHTTRECQL
Hydrochloric Acid SCHEMBL1417761 0.89 ALDH1A1 (0.45) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL2626703 0.88 ALDH1A1 (0.42) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL8664938 0.88 KDM4E (0.50) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL5809049 0.83 ALDH1A1 (0.47) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL8431293 0.82 KDM4E (0.43) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL7309807 0.82 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL27336187 0.81 PIN1 (0.38) KDM4ECYP1A2CYP2C19MAPK1POLB
SCHEMBL9137641 0.80 ALDH1A1 (0.65) ALDH1A1HPGDKDM4EHTTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109384771-B Olmesartan medoxomil related impurities and preparation method thereof 成都倍特药业股份有限公司 2020-11-06 CN disclosed
EP-0503785-B1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-04-25 EP disclosed
EP-0545912-B1 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-04-25 EP disclosed
US-5646171-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1997-07-08 US disclosed
US-5616599-A HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER SANKYO COMPANY, LIMITED (JP) 1997-04-01 US disclosed
EP-0545912-A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1993-06-09 EP disclosed
EP-0503785-A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1992-09-16 EP disclosed